Abstract: A novel polypeptide, acylglucosamine 2-epimerase as shown in FIG. 1 and derivatives thereof, DNA coding for said enzyme, a recombinant vector containing said enzyme, a transformant integrated thereinto said vector, a method for producing said enzyme and a method for producing N-acetylmannosamine and N-acetylneuraminic acid using renin binding protein.
Abstract: In a method of quantifying sulfate-conjugated bile acid in a sample with bile acid sulfate sulfatase and a reductive system indicator, an 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt is used as a reductive system indicator. Sulfate-conjugated bile acid can be quantified through a single reaction without complication.
Abstract: A novel polypeptide, acylglucosamine 2-epimerase as shown in FIG. 1 and derivatives thereof, DNA coding for said enzyme, a recombinant vector containing said enzyme, a transformant integrated thereinto said vector, a method for producing said enzyme and a mrthod for producing N-acetylmannosamine and N-acetylneuraminic acid using renin binding protein.
Abstract: A method for preparing N-acetylneuraminic acid characterized in reacting N-acetylglucosamine with pyruvic acid in an alkaline condition by the action of N-acetylneuraminic acid lyase.
Abstract: A sulfate ester of N-acetylneuraminic acid homopolymer represented by the formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein R represents H or SO.sub.3 H, n is 5-1,000, wherein the number of SO.sub.3 H residues per 1 molecule of N-acetylneuraminic acid residues is 0.1 to 3.0, which sulfate ester demonstrates anti-HIV activity.
Abstract: The present invention relates to a bile acid sulfate sulfatase gene coding for the amino acid sequence as shown in FIG. 4 and the gene derived from bacteria which belongs to genus Pseudomonas testosteroni, or a bile acid sulfate sulfatase gene as shown in FIG. 3, a plasmid containing the gene, a method for producing a bile acid sulfate sulfatase, and a bile acid sulfate sulfatase.
Abstract: A method for preparing N-acetylneuraminic acid characterized in reacting N-acetylglucosamine with pyruvic acid at an alkaline pH in the presence of N-acetylneuraminic acid lyase.
Abstract: The present invention provides a process for preparing ganglioside G.sub.Ml characterized in that neuraminidase isozyme S is allowed to act on gangliosides to produce ganglioside G.sub.Ml.
Abstract: The present invention provides a process for preparing asialo G.sub.M1 characterized in that neuraminidase isozyme L is allowed to act on gangliosides to produce asialo G.sub.M1.
Abstract: The present invention provides a process for preparing neuraminidase comprising incubating a mutant of the genus Arthrobacter capable of producing neuraminidase in the absence of any inducing substance, and recovering neuraminidase from the resulting culture.
Abstract: The invention provides a novel bile acid sulfate sulfatase, a process for its preparation, and a method of assaying bile acid 3.alpha.-sulfates and total bile acids using the bile acid sulfatase.
Abstract: The invention provides a novel bile acid sulfate sulfatase, a process for its preparation, and a method of assaying bile acid 3.alpha.-sulfates and total bile acids using the bile acid sulfatase.
Abstract: This invention provides a process for producing N-acylneuraminate aldolase comprising incubating a mutant of the genus Escherichia capable of producing N-acylneuraminate aldolase even in the absence of any inducing substance, and collecting N-acylneuraminate aldolase from the resulting culture.